Semaglutide lessens blood glucose via a mechanism where it stimulates insulin secretion and lowers glucagon secretion, each in a glucose-dependent way.Unique Populations Determined by a populace pharmacokinetic analysis, age, sex, race, and ethnicity, and renal impairment do not need a clinically significant impact on the pharmacokinetics of semagl